Gts Securities LLC Direxion Daily S&P Biotech Bea Transaction History

Gts Securities LLC

$45.4 Billion
Q3 2024

A detailed history of Gts Securities LLC transactions in Direxion Daily S&P Biotech Bea stock. As of the latest transaction made, Gts Securities LLC holds 12,400 shares of LABD stock, worth $86,304. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,400

Previous 38,300 67.62%

Holding current value

$86,304

Previous $280,000 74.29%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$5.29 - $7.77 $195,671 - $287,404	36,989 Added 78.46%	84,130 $491,000
Q2 2024 Aug 14, 2024	SELL	$7.1 - $11.03 $325,748 - $506,056	-45,880 Reduced 49.32%	47,141 $345,000
Q1 2024 May 15, 2024	BUY	$5.9 - $10.3 $320,163 - $558,929	54,265 Added 140.02%	93,021 $678,000
Q4 2023 Feb 14, 2024	SELL	$9.2 - $29.48 $74,722 - $239,436	-8,122 Reduced 17.33%	38,756 $375,000
Q3 2023 Nov 15, 2023	BUY	$13.11 - $21.68 $257,126 - $425,209	19,613 Added 71.93%	46,878 $965,000
Q2 2023 Aug 15, 2023	BUY	$11.41 - $21.44 $311,093 - $584,561	27,265 New	27,265 $392 Million

Others Institutions Holding LABD

# of Institutions

Shares Held

5.14M

Call Options Held

1.33M

Put Options Held

255K

View Full List

About DIREXION DAILY S&P BIOTECH BEA

Ticker LABD
Sector ETFs
Industry ETFs

More about LABD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Account

Gts Securities LLC Direxion Daily S&P Biotech Bea Transaction History